PRESS RELEASE
News
-
-
PRESS RELEASE
Gladstone Land Announces Increase in Monthly Cash Distributions for January, February and March 2024 and Earnings Release and Conference Call Dates for the Fourth Quarter Ended December 31, 2023
Gladstone Land Corporation (NASDAQ: LAND) has declared cash distributions for January, February, and March 2024 for its common stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, and Series E Preferred Stock. The Company also announced plans to report earnings for the fourth quarter ended December 31, 2023 and will hold a conference call to discuss its earnings results. -
PRESS RELEASE
Gladstone Investment Announces Monthly Cash Distributions for January, February and March 2024, and Earnings Release and Conference Call Dates for the Third Fiscal Quarter
Gladstone Investment Corporation (NASDAQ:GAIN) has declared monthly cash distributions to common stockholders for January, February, and March 2024, along with plans to report earnings for its third fiscal quarter ended December 31, 2023. The company also offers a dividend reinvestment plan and will hold a conference call to discuss its earnings results. For more information, visit www.gladstoneinvestment.com. For investor relations inquiries, please contact (703) 287-5893. -
PRESS RELEASE
Gladstone Capital Announces Monthly Cash Distributions for January, February and March 2024 and Conference Call Date
Gladstone Capital Corporation (NASDAQ: GLAD) has declared its monthly cash distributions for January, February, and March 2024, for both its common and preferred stock. The Company also announced its plan to report earnings for its first fiscal quarter ended December 31, 2023, and will hold a conference call to discuss the results. For more information, visit www.gladstonecapital.com. -
PRESS RELEASE
Blue Lagoon Announces Private Placement
Blue Lagoon Resources Inc. (CSE:BLLG)(FSE:7BL)(OTCQB:BLAGF) announces a private placement offering of common shares (the 'Private Placement') of up to $1,000,000 at a price of $0.14 per share. Proceeds will be used to advance the Company's Dome Mountain gold project. For further information, please contact Rana Vig, President and Chief Executive Officer, at 604-218-4766 or email rana@ranavig.com. -
PRESS RELEASE
WCH Service Bureau Joins Integra Partners GPO Program
Integra Partners Group Purchasing Organization (GPO) has expanded to include WCH Service Bureau, a nationally recognized healthcare company offering audit prevention services at a special discount to participating Integra Providers. This strategic alliance aims to minimize audit risks and ensure compliance with stringent regulations, protecting healthcare organizations from liability and potential penalties. The partnership exemplifies the power of strategic alliances in promoting trust and fostering long-lasting relationships with clients. For more information, visit the press release on newswire.com. -
PRESS RELEASE
AlayaCare Named Best Software as a Service (outside USA) in the 2023-2024 Cloud Awards
AlayaCare has been declared a winner in the 2023-2024 Cloud Awards program for Best Software as a Service (outside USA). The Cloud Awards program recognizes and honors innovation in cloud computing, with categories such as Best Use of AI in Cloud Computing and Best Cloud Business Intelligence or Analytics Solution. AlayaCare's CEO, Adrian Schauer, credits the company's focus on cutting-edge solutions for their win, emphasizing their commitment to innovation and advanced technologies like machine learning and AI. The Cloud Awards program, which has been recognizing industry leaders in cloud computing since 2011, will return in autumn 2024. For more information, including the complete list of winners, please visit the official Cloud Awards website. -
PRESS RELEASE
Cloud DX Signs 6-Figure Contract to Design New Wearable; Company Will Present at a Webinar and 4 Investor Conferences
Cloud DX, a leading provider of virtual care and remote patient monitoring platforms, has been retained to design a new wearable device aimed at tracking vital signs related to overall health and wellness. With a contract valued at $115,000 CAD for Phase 1 and a 4.5% royalty on gross profits for every device sold, Cloud DX is poised to embark on a long and fruitful partnership to create a consumer-grade wearable device that aims to improve health and wellness at every level. CEO Robert Kaul is set to discuss the company's recently announced milestones and the 2024 outlook at an upcoming webinar on January 17, 2024, at 4:00 PM EST, with additional appearances at various investor conferences in the coming weeks. The new wearable device, leveraging Cloud DX's 10 years of experience in medical device design and manufacturing, is aimed at helping users reduce the impact of stress, build resilience, and live longer, more fulfilled lives. -
PRESS RELEASE
Lighthouse (Formerly OTA Insight) Wins Four 2024 HotelTechAwards, Reinforcing Leadership in Hospitality Technology
Lighthouse, formerly OTA Insight, has been honored with multiple awards in the travel and hospitality industry, marking the fourth consecutive year of recognition. The company's dedication to innovation, data quality, and customer service has been showcased through its unprecedented success in categories such as Best Rate Shopping & Market Intelligence, Best Hotel Rate Parity, and Best Business Intelligence. The rebranding to Lighthouse in 2023 has introduced new features and reinforced the company's commitment to empowering hoteliers with cutting-edge solutions and insights. Sean Fitzpatrick, the CEO of Lighthouse, expressed immense pride in receiving the awards and emphasized the company's unwavering commitment to excellence and customer success. The Hotel Tech Report Awards, known for acknowledging outstanding technology providers in the global hotel industry, have once again recognized Lighthouse for its exceptional performance. Lighthouse's reputation for rapid innovation and top-tier customer support has solidified its position as a leader in the industry, catering to a diverse range of hoteliers across the globe. -
PRESS RELEASE
ZetrOZ Systems’ sam 2.0 Wearable Ultrasound Unit Receives New FDA Clearance for Expanded Medical Indications
ZetrOZ Systems' sam® 2.0 long-duration wearable ultrasound unit has received clearance from the U.S. Food and Drug Administration for expanded indications to treat soft tissue injuries and knee osteoarthritis, making the sustained acoustic medicine device more accessible to a wider range of medical conditions. The FDA's decision signifies the device's safety and effectiveness, paving the way for increased utilization in both professional sports and general population healthcare. The company's founder and CEO, George K. Lewis, highlights the significance of the FDA clearance, emphasizing the numerous studies demonstrating the technology's efficacy in treating injuries without the need for oral medication, corticosteroids, or surgery.
